Medico Remedies Share Price

₹ 19.00

+₹0.39 (2.10%)

Last updated 02 Nov, 2026, 15:29 IST

NSE: MEDICO

Medico Remedies Share Price Today

As of 2 Nov 2026, Medico Remedies share price is ₹19.00. The stock opened at ₹18.60, compared to its previous close of ₹18.61. During today's trading session, Medico Remedies share price moved in the range of ₹18.36 to ₹19.44, with an average price of ₹18.90 for the day. Looking at its last 52-week, the stock has touched a low of ₹18.36 and a high of ₹56.88. On the performance front, Medico Remedies share price has declined by 55.58% over the last six months and is down 62.60% on a year-on-year basis.

₹18.36

2.10% up today

₹19.44

1D LOW

1D HIGH

Medico Remedies Stock Insights

Stock Performance

UnderperformingUnderperforming Nifty by 51.86 % in last 1 yr

Shareholding Pattern

FIIFII increased stake by 668.85%

Medico Remedies Stock Insights

Stock Performance

UnderperformingUnderperforming Nifty by 51.86 % in last 1 yr

Shareholding Pattern

FIIFII increased stake by 668.85%

Medico Remedies stock performance
Open	₹18.60
High	₹19.44
Low	₹18.36
Prev. close	₹18.61

Medico Remedies trading activity
Volume	97,205
Average traded price	₹18.94
Last traded time	03:29:38 02 Nov
Last traded quantity	500

₹16.75₹20.47

Circuit Low

Circuit High

₹18.36₹56.88

52-Week Low

52-Week High

Circuit

₹16.75

₹20.47

52-week

₹18.36

₹56.88

Mkt Cap Cr

154.77

P/E

11.23

P/B

2.05

ROA

9.01%

ROE

17.38%

ROCE

20.98%

Quick Ratio

1.27

EV/EBITDA

7.16

Mkt Cap Cr

154.77

P/E

11.23

P/B

2.05

ROA

9.01%

ROE

17.38%

ROCE

20.98%

Quick Ratio

1.27

EV/EBITDA

7.16

Based on fundamentals, this stock's

Performance

Very Poor

Medico Remedies has not beaten FD return of 7%

Valuation

Overvalued

Medico Remedies appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Sun Pharmaceutical Industries	4,26,661.74	38.83	4.78	9.61%	13.79%	18.65%	2.31	22.27
Divis Laboratories	2,57,902.73	88.17	15.39	14.6%	15.32%	19.56%	3.5	58.97
Torrent Pharmaceuticals	1,76,306.21	84.0	9.6	4.7%	11.42%	11.37%	0.75	33.6
Laurus Labs	1,29,242.68	97.0	21.33	11.58%	22.11%	20.91%	0.68	54.77
Zydus Lifesciences	1,24,089.48	27.02	4.58	8.57%	18.59%	17.35%	0.91	16.42
Dr. Reddy's Laboratories	1,12,698.53	40.84	2.9	4.79%	7.21%	8.58%	1.35	19.05
Cipla	1,11,486.14	39.06	3.15	6.6%	8.18%	10.8%	2.5	21.03
Mankind Pharma	1,02,796.60	45.42	5.85	7.82%	12.76%	14.68%	0.74	25.01
Aurobindo Pharma	96,536.90	26.02	2.55	6.34%	9.25%	11.76%	1.15	12.38
Lupin	91,870.16	16.55	4.09	14.47%	23.76%	24.88%	1.42	9.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Medico Remedies Company Background

ISIN

INE630Y01024

Sector Market Cap

₹ 154.77 Cr

Medico Remedies Limited is an India-based company, principally engaged in the pharmaceutical business. The Company is involved in the development, manufacture and sale of pharmaceutical and nutraceutical products. It focuses on anti-infective, Beta-Lactams, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, hematinic and other supplements. The Company also manufactures and markets capabilities in other drugs such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Pediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others. Its syrups include Medivit Syrup and Ferrovit Syrup.

Medico Remedies Financial Highlights

Revenue: Medico Remedies reported revenue of ₹212.31 crore in FY26 vs ₹153.63 crore in FY25. It showed an increase of 38.20% on a yearly basis.
Operating Profit: Medico Remedies reported an operating profit of ₹18.06 crore in FY26 vs ₹13.50 crore in FY25. It showed an increase of 33.78% on a year-on-year basis.
Net Profit: Medico Remedies reported a net profit of ₹13.12 crore in FY26 vs ₹10.09 crore in FY25. It showed an increase of 30.03% on a yearly basis.

Medico Remedies Quarterly Result Highlights

Medico Remedies reported revenue of ₹70.57 crore in Jun 2026, compared with ₹59.68 crore in Mar 2026, representing an increase of 18.25% on a quarter-on-quarter (QoQ) basis.
Medico Remedies reported an operating profit of ₹3.34 crore in Jun 2026, compared with ₹8.32 crore in Mar 2026, representing a decrease of 59.86% on a quarter-on-quarter (QoQ) basis.
Medico Remedies reported a profit of ₹2.52 crore in Jun 2026, compared with ₹5.86 crore in Mar 2026, reflecting a decrease of 57.00% on a QoQ basis.
The earnings per share (EPS) of Medico Remedies stood at ₹1.58 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters

61.38%

FII

0.60%

Other DII

0.00%

Retail and other

38.02%

Mutual funds

0.00%

Foreign Institutional Investor (FII)

FII shareholding by period
Dec 2025	0.49%
Mar 2026	0.03%
Jun 2026	0.08%
Sep 2026	0.60%

Medico Remedies Investment Returns

1 day

+1.40%

1 week

-6.03%

1 month

-13.68%

1 year

-62.60%

3 years

-75.09%

5 years

-22.02%

Medico Remedies Share Price History

Medico Remedies share price history by day, showing open and close prices and the percentage change
Day	Open / Close	Change %
30 Oct 26	₹19.30 / ₹18.61	-1.95%
29 Oct 26	₹19.59 / ₹18.98	-1.25%
28 Oct 26	₹20.69 / ₹19.22	-5.88%
27 Oct 26	₹20.24 / ₹20.42	+1.69%
26 Oct 26	₹20.28 / ₹20.08	+0.90%
23 Oct 26	₹20.55 / ₹19.90	-2.93%
22 Oct 26	₹20.97 / ₹20.50	-1.35%
21 Oct 26	₹21.80 / ₹20.78	-3.03%
19 Oct 26	₹22.04 / ₹21.43	-2.72%
16 Oct 26	₹22.30 / ₹22.03	+0.55%

Medico Remedies Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹206.38	₹150.94	₹144.92	₹140.44
Other Income	₹5.93	₹2.69	₹2.13	₹3.95
Total Revenue	₹212.31	₹153.63	₹147.05	₹144.38
Total Expenses	₹194.25	₹140.13	₹135.71	₹134.29
Profit Before Tax	₹18.06	₹13.50	₹11.33	₹10.10
Tax	₹4.94	₹3.41	₹3.04	₹2.86
Profit After Tax	₹13.12	₹10.09	₹8.29	₹7.24
EPS - Basic	₹1.58	₹1.22	₹1.00	₹0.87
EPS - Diluted	₹1.58	₹1.22	₹1.00	₹0.87

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹18.06	₹13.50	₹11.33	₹10.10
Income before WC changes	₹21.25	₹15.94	₹14.86	₹12.81
Change in Assets	-₹31.41	-₹21.33	-₹9.66	-₹6.39
Change in Liabilities	₹21.10	₹14.08	₹0.40	₹4.24
Change in WC	-₹10.32	-₹7.25	-₹9.26	-₹2.15
Cash flow from Operations	₹5.87	₹4.89	₹2.44	₹8.17
Cash flow from Investing	-₹4.51	-₹3.46	-₹2.68	-₹6.60
Cash flow from Financing	-₹0.55	-₹0.52	-₹0.49	-₹1.82
Total Cash Flow	₹0.81	₹0.91	-₹0.73	-₹0.25
Cash (Start of the year)	₹1.09	₹0.18	₹0.91	₹1.17
Cash (End of the year)	₹1.91	₹1.10	₹0.18	₹0.91

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹24.49	₹23.12	₹22.48	₹22.91
Current Assets	₹128.92	₹96.68	₹73.71	₹64.54
Total Assets	₹153.40	₹119.80	₹96.20	₹87.45
Current Liabilities	₹77.64	₹56.96	₹42.81	₹41.77
Net Current Asset	₹51.28	₹39.71	₹30.90	₹22.77
Non-Current Liabilities	₹0.29	₹0.37	₹1.01	₹1.84
Equity Capital	₹75.47	₹62.47	₹52.37	₹43.84
Total Equity & Liabilities	₹153.40	₹119.80	₹96.20	₹87.45